Clinical and In-Silico Analysis of Thyroid Dysfunction and Type 2 Diabetes Risk in Non-Diabetic Iraqi Patients with Subclinical Hypothyroidism
DOI:
https://doi.org/10.48048/tis.2025.10093Keywords:
Diabetes mellitus, Insulin resistance, T2DM, Hypothyroidism, Thyroid dysfunction, SCHAbstract
Thyroid dysfunction and type 2 diabetes mellitus (T2DM) are interconnected endocrine disorders, yet their causal relationship remains unclear. This study investigates the impact of subclinical hypothyroidism (SCH) on the risk of developing insulin resistance, prediabetes, and T2DM in non-diabetic Iraqi subjects. A total of 300 SCH patients and 200 healthy controls were assessed for fasting blood glucose (FBG), fasting insulin (FI), glycosylated hemoglobin (HbA1c), thyroid-stimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3) at baseline and after 16 months without treatment. Insulin resistance was evaluated using the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). The interaction between thyroid hormones and the insulin receptor tyrosine kinase was investigated using molecular docking methodologies. Results showed that 49 % of SCH patients developed clinical hypothyroidism, while all participants exhibited insulin resistance by the follow-up period. After the follow-up period, 73 % of the patients developed prediabetes, and 27 % progressed to T2DM. Molecular docking analyses revealed direct interactions between T3, T4, and the insulin receptor, suggesting a modulatory role of thyroid hormones in insulin signaling. It is concluded that untreated SCH significantly increases the risk of metabolic disorders, supporting thyroid dysfunction as a causative factor in diabetes development. Early detection and management of SCH could be critical in preventing T2DM onset.
HIGHLIGHTS
- The study demonstrates that untreated subclinical hypothyroidism significantly increases the risk of insulin resistance, prediabetes, and type 2 diabetes mellitus in non-diabetic individuals.
- Computational analysis shows direct interactions between T3, T4, and the insulin receptor tyrosine kinase, supporting the potential modulatory role of thyroid hormones in insulin signaling and glucose metabolism.
- The findings highlight the importance of early detection and management of subclinical hypothyroidism to prevent metabolic disorders, supporting the role of thyroid dysfunction as a causative factor in diabetes development rather than a consequence.
GRAPHICAL ABSTRACT
Downloads
References
C Wang. The relationship between type 2 diabetes mellitus and related thyroid diseases. Journal of Diabetes Research 2013; 2013, 390534.
M Hage, MS Zantout and ST Azar. Thyroid disorders and diabetes mellitus. Journal of Thyroid Research 2011; 2011, 439463.
K Vondra, J Vrbikova and K Dvorakova. Thyroid gland diseases in adult patients with diabetes mellitus. Minerva Endocrinology 2005; 30(4), 217-236.
B Biondi, GJ Kahaly and RP Robertson. Thyroid dysfunction and diabetes mellitus: Two closely associated disorders. Endocrine Reviews 2019; 40(3), 789-824.
O Dueñas, A Burgh, T Ittermann, S Ligthart, MA Ikram, R Peeters and L Chaker. Thyroid function and the risk of prediabetes and type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism 2022; 107(6), 1789-1798.
SMM Hussein and RM AbdElmageed. The relationship between type 2 diabetes mellitus and related thyroid diseases. Cureus 2021; 13(12), e20697.
RH Chen, HY Chen, KM Man, SJ Chen, W Chen, PL Liu, YH Chen and WC Chen. Thyroid diseases increased the risk of type 2 diabetes mellitus: A nation-wide cohort study. Medicine 2019; 98(20), e15631.
H Rashidi, SB Ghaderian, SM Latifi and F Hoseini. Impact of diabetic ketoacidosis on thyroid function tests in type 1 diabetes mellitus patients. Diabetology & Metabolic Syndrome 2017; 11(S1), S57-S59.
J Wang, H Li, M Tan, G Gao, Y Zhang, B Ding, X Su, X Kong and J Ma. Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: A cross-sectional study in China. Oncotarget 2019; 10(2), 88-97.
J Zou, Z Li, F Tian, Y Zhang, C Xu, J Zhai, M Shi, G Wu, Z Zhang, C Yang, H Chen and X Li. Association between normal thyroid hormones and diabetic retinopathy in patients with type 2 diabetes. BioMed Research International 2020; 2020, 8161797.
S Zhang, G Feng, F Kang, Y Guo, H Ti, L Hao, P Gao and J Gao. Hypothyroidism and adverse endpoints in diabetic patients: A systematic review and meta-analysis. Frontiers in Endocrinology 2020; 10, 889.
Y Li, M Yi, X Deng, W Li, Y Chen and X Zhang. Evaluation of the thyroid characteristics and correlated factors in hospitalized patients with newly diagnosed type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 2022; 15, 873-884.
C Aguayo-Mazzucato, AM Zavacki, A Marinelarena, J Hollister-Lock, I El Khattabi, A Marsili, GC Weir, A Sharma, PR Larsen and S Bonner-Weir. Thyroid hormone promotes postnatal rat pancreatic β-cell development and glucose-responsive insulin secretion through MAFA. Diabetes 2013; 62(5), 1569-1580.
CV Falzacappa, C Mangialardo, L Madaro, D Ranieri, L Lupoi, A Stigliano, MR Torrisi, M Bouchè, V Toscano and S Misiti. Thyroid hormone T3 counteracts STZ induced diabetes in mouse. PLoS One 2011; 6(5), e19839.
M Nishi. Diabetes mellitus and thyroid diseases. Diabetology International 2018; 9(2), 108-112.
EA Park, DC Jerden and SW Bahouth. Regulation of phosphoenolpyruvate carboxykinase gene transcription by thyroid hormone involves two distinct binding sites in the promoter. Biochemical Journal 1995; 309(Pt3), 913-919.
EA Park, S Song, C Vinson and WJ Roesler. Role of CCAAT enhancer-binding protein beta in the thyroid hormone and cAMP induction of phosphoenolpyruvate carboxykinase gene transcription. Journal of Biological Chemistry 1999; 274(1), 211-217.
M Hage, MS Zantout and ST Azar. Thyroid disorders and diabetes mellitus. Journal of Thyroid Research 2011; 2011, 439463.
LP Klieverik, SF Janssen, A van Riel, E Foppen, PH Bisschop, MJ Serlie, A Boelen, MT Ackermans, HP Sauerwein, E Fliers and A Kalsbeek. Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver. Proceedings of the National Academy of Sciences of the United States of America 2009; 106(14), 5966-5971.
M Paramasivam, R Mohan and TS Shanmugarajan. KAP study on thyroid disorders (hypothyroidism and hyperthyroidism) in a tertiary care hospital. Research Journal of Pharmacy and Technology 2017; 10(1), 41-43.
DS Cooper. Subclinical hypothyroidism. The New England Journal of Medicine 2001; 345(4), 260-265.
V Fatourechi. Subclinical hypothyroidism: An update for primary care physicians. Mayo Clinic Proceedings 2009; 84(1), 65-71.
CCSSV Palma, M Pavesi, VG Nogueira, ELS Clemente, MDFBMP Vasconcellos, LCP Júnior, FF Pacheco, TG Braga, LDF Bello, JO Soares, SCFD Santos, VPLC Campos and MB Gomes. Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetology & Metabolic Syndrome 2013; 5(1), 58.
S Khatiwada, R KC, SK Sah, SA Khan, RK Chaudhari, N Baral and M Lamsal. Thyroid dysfunction and associated risk factors among Nepalese diabetes mellitus patients. International Journal of Endocrinology 2015; 2015(167), 570198.
S Khatiwada, SK Sah, R KC, N Baral and M Lamsal. Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome. Clinical Diabetes and Endocrinology 2016; 2(1), 3.
L Demitrost and S Ranabir. Thyroid dysfunction in type 2 diabetes mellitus: A retrospective study. Indian Journal of Endocrinology and Metabolism 2012; 16(S2), S334 -S335.
NZ Khan, MA Muttalib, GS Sultana, FA Mishu and A Nesa. Study of thyroid disorders among type 2 diabetic patients attending a tertiary care hospital. Mymensingh Medical Journal 2017; 26(4), 874-878.
DR Matthews, JP Hosker, AS Rudenski, BA Naylor, DF Teacher and RC Turner. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28(7), 412-419.
S Kim, J Chen, T Cheng, A Gindulyte, J He, S He, Q Li, BA Shoemaker, PA Thiessen, B Yu, L Zaslavsky, J Zhang and E Bolton. Nucleic Acids Research 2023; 51(D1), D1373-D1380.
JH Till, AJ Ablooglu, M Frankel, SM Bishop, RA Kohanski and SR Hubbard. Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: Insights into kinase mechanism. Journal of Biological Chemistry 2001; 276(13), 10049-10055.
Chemical Computing Group Inc. Molecular operating environment (MOE). Chemical Computing Group Inc., Quebec, Canada, 2016.
EF Pettersen, TD Goddard, CC Huang, GS Couch, DM Greenblatt, EC Meng and TE Ferrin. UCSF Chimera - a visualization system for exploratory research and analysis. Journal of Computational Chemistry 2004; 25(13), 1605-1612.
P Zhou, F Tian and Z Shang. 2D depiction of nonbonding interactions for protein complexes. Journal of Computational Chemistry 2009; 30(6), 940-951.
KAM White, S Daneshvari, J Lilyquist, L Luo, LE Steffen, A Bivin, N Gurule, GM Ducasa, SM Torres, R Lindeman, S Sankarappan and M Berwick. Prediabetes: The variation between HbA1c and fasting plasma glucose. Diabetology & Vascular Disease Research 2015; 2015(S2), 001.
E Bonora, G Targher, M Alberiche, RC Bonadonna, F Saggiani, MA Zenere, T Monauni and M Muggeo. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23(1), 57-63.
G Dimitriadis, M Parry-Billings, S Bevan, B Leighton, U Krause, T Piva, K Tegos, R A Challiss, G Wegener and EA Newsholme. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. European Journal of Clinical Investigation 1997; 27, 475-483.
P Cettour-Rose, C Theander-Carrillo, C Asensio, M Klein, TJ Visser, AG Burger, CA Meier, F Rohner-Jeanrenaud. Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion. Diabetologia 2005; 48(4), 624-633.
C Rochon, I Tauveron, C Dejax, P Benoit, P Capitan, A Fabricio, C Berry, C Champredon, P Thieblot and J Grizard. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clinical Science 2003; 104(1), 7-15.
TL Althausen and M Stockholm. The influence of the thyroid gland on absorption in the digestive tract. American Journal of Physiology 1938; 123, 577-588.
S Stanická, K Vondra, T Pelikánová, P Vlček, M Hill and V Zamrazil. Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clinical Chemistry and Laboratory Medicine 2005; 43(7), 715-720.
SMM Hussein and RM AbdElmageed. The relationship between type 2 diabetes mellitus and related thyroid diseases. Cureus 2021; 13(12), e20697.
OHR Dueñas, ACVD Burgh, T Ittermann, S Ligthart, MA Ikram, R Peeters and L Chaker. Thyroid function and the risk of prediabetes and type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism 2022; 107(6), 1789-1798.
CC Palma, M Pavesi, VG Nogueira, ES Clemente, MDFBMP Vasconcellos, LCP Júnior, FF Pacheco, TG Braga, LDF Bello, JO Soares, SCFD Santos, VPLC Campos and MB Gomes. Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetology & Metabolic Syndrome 2013; 5(1), 58.
MV Jali, S Kambar, SM Jali, N Pawar and P Nalawade. Prevalence of thyroid dysfunction among type 2 diabetes mellitus patients. Diabetes & Metabolic Syndrome 2017; 11(S1), S105-S108.
SU Ogbonna and IU Ezeani. Risk factors of thyroid dysfunction in patients with type 2 diabetes mellitus. Frontiers in Endocrinology 2019; 10, 440.
M Ozair, S Noor, A Raghav, SS Siddiqi, AM Chugtai and J Ahmad. Prevalence of thyroid disorders in North Indian type 2 diabetic subjects: A cross sectional study. Diabetology & Metabolic Syndrome 2018; 12(3), 301-304.
S Vemula, S Aramadaka, R Mannam, RS Narayanan, A Bansal, VR Yanamaladoddi and SS Sarvepalli. The impact of hypothyroidism on diabetes mellitus and its complications: A comprehensive review. Cureus 2023; 15(6), e40447.
A Mancini, C Di Segni, S Raimondo, G Olivieri, A Silvestrini, E Meucci and D Curro. Thyroid hormones, oxidative stress, and inflammation. Mediators of Inflammation 2016; 2016, 12.
J Whittaker, P García and K Siddle. The structural basis of insulin receptor activation and its implications for drug design. Nature Reviews Endocrinology 2021; 17(10), 682-698.
Y Xu, X Liu and Y Zhang. Ligand flexibility and its role in molecular docking to tyrosine kinases. Journal of Molecular Recognition 2020; 33(5), e2827.
P Cettour-Rose, AG Burger, H Mentz, et al. Thyroid hormones and insulin signaling: Interplay and metabolic implications. Endocrine Reviews 2022; 43(2), 314-329.
P Kumar, S Jain and A Verma. Small molecule inhibitors targeting tyrosine kinase receptors: Advances and therapeutic implications. Biochimica et Biophysica Acta - Proteins and Proteomics 2022; 1869(3), 140711.
M Díaz-Flores, J Angeles-Martínez and S Olguín-Reyes. Hypothyroidism and its role in insulin resistance: Mechanistic insights. Journal of Endocrinology and Metabolism 2022; 17(4), 275-290.
Published
Issue
Section
License
Copyright (c) 2025 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
